Liver transplantation for hepatocellular carcinoma: An update

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 4, Issue 8, 2006, Pages 762-767

  Botha, Jean F ^a,b   Langnas, Alan N ^a,b  

^a Nebraska Medical Center ^*

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Adjuvant therapy; Hepatocellular carcinoma; Liver transplantation; Living donors

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 2; TACROLIMUS;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PATIENT SELECTION; PRACTICE GUIDELINE; RADIOFREQUENCY ABLATION; RECURRENCE RISK; UNITED STATES;

EID: 33748803594     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2006.0066     Document Type: Article

References (35)

1. Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985;202:401-407.
2. Ringe B, Wittekind C, Bechstein WO, et al. The role of liver transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 1989;23(suppl):S104-S109.
3. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991;110:726-735.
4. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-229.
5. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-285.
6. Olthoff KM, Millis JM, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990;125:1261-1268.
7. Bismuth H, Chiche L, Adam R, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151.
8. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
9. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33:1080-1086.
10. Llovet J, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
11. Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15.
12. Befeler AS, Hyashi PH, Bisceglie AM. Liver transplantation for hepatocellular carinoma. Gastroenterology 2005;128:1752-1764.
13. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765-774.
14. Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 2003;9:693-696.
15. Sauer P, Kraus TW, Schemmer P, et al. Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the criteria? Transplantation 2005;80(1 Suppl):S105-S108.
16. Lohe F, Angele MK, Gerbes AL, et al. Tumor size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol 2005;31:994-999.
17. Ismail T, Angrisani L, Gunson BK, et al. Primary hepatic malignancy: the role of liver transplantation. Br J Surg 1990;77:983-987.
18. McPeake JR, O'Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 1993;18:226-234.
19. Selby R, Kadry Z, Carr B, et al. Liver transplantation for hepatocellular carcinoma. World J Surg 1995;19:53-58.
20. Koo J, Fung K, Siu KF, et al. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma. Cancer 1983;52:1952-1956.
21. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced stage hepatocellular carcinoma. Hepatology 1995;21:403-407.
22. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-703.
23. Perez Saborido B, Meneu JC, Moreno E, et al. Is transarterial chemoembolization necessary before liver transplantation fot hepatocellular carcinoma? Am J Surg 2005;190:383-387.
24. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, et al. Impact of pre-transplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005;11:767-775.
25. Porrett PM, Peterman H, Rosen M, et al. Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 2006;12:665-673.
26. Botha JF, Campos BD, Grant WJ, et al. Should hepatocellular carcinoma be treated during the waiting list period? (abstract) Am J Transplant 2004;(suppl 8):Abstract#1389.
27. Yao FY, Hirose R, LaBerge JM, et al. A prospective study on down-staging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005;11:1505-1514.
28. Yokoyama I, Carr B, Saitsu H, et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991;68:2095-2100.
29. Frunam DA, Kiee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci USA 1992;89:3686.
30. Reizenstein P, Ogier C, Blomgren H, et al. Cells responsible for tumor surveillance in man: effects of radiotherapy, chemotherapy, and biologic response modifiers. Adv Immun Cancer Ther 1985;1:1-28.
31. Azoulay D, Astarcioglu I, Bismuth H, et al. Split-liver transplantation. The Paul Brousse policy. Ann Surg 1996;224:737-746; discussion 746-748.
32. Busuttil RW, Goss JA. Split liver transplantation. Ann Surg 1999;229:313-321.
33. Rogiers X, Malago M, Gawad K, et al. In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg 1996;224:331-339; discussion 339-341.
34. Cheng SJ, Pratt DS, Freeman RB Jr, et al. Living-donor versus cadaveric liver transplantation for unresectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001;72:861-868.
35. Gondolesi G, Munoz L, Matsumoto C, et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg 2002;6:102-107.